Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of pectin-doxorubicin conjugate and its preparation method and application

A technology of doxorubicin and conjugates, applied in the field of pectin-doxorubicin conjugates and their preparation, can solve the problems of only topical medication, poor anti-tumor effect, insoluble in water and the like

Active Publication Date: 2022-04-12
SICHUAN YINGRUI PHARMA TECH CO
View PDF12 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The existing pectin-doxorubicin conjugates are pectin and doxorubicin bonded directly through amide bonds or acylhydrazone bonds, which are difficult to dissolve in water and must be made into nano-suspensions or freeze-dried powder injections , can only be used locally; if it is used systemically, it is easy to be swallowed by the reticuloendothelial system, the targeting is limited, and it cannot be accumulated in malignant tumor tissues at high concentrations for a long time, and the anti-tumor effect is not good.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of pectin-doxorubicin conjugate and its preparation method and application
  • A kind of pectin-doxorubicin conjugate and its preparation method and application
  • A kind of pectin-doxorubicin conjugate and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] 150g of Compound 1 (0.44mol) was dissolved in 1.5 LTHF, NHS (56g, 0.49mol) and DCC (137g, 0.66mol) were added successively, stirred overnight at room temperature, filtered, washed twice with solid dichloromethane, the filtrate was concentrated to dryness, and weighed After one crystallization, the pure product of compound 2 can be obtained.

Embodiment 2

[0035]

[0036] 147g of compound 2 (0.34mol) was dissolved in 1.5 LTHF, followed by adding L-alanine (32g, 0.35mol), NaHCO 3 (30g, 0.35mol), and then add 500mL of water. Adjust the ratio of THF and water to make the reaction solution into a single phase (difficult). Stir overnight at room temperature. After the reaction is complete, concentrate to remove THF, dilute with water, adjust the pH to 3-4 with HCl, and precipitate a solid. The solid is washed with water, dried in vacuo, and washed with ethyl acetate to obtain 130 g of product 3 (containing a little impurity), which is purified by crystallization.

Embodiment 3

[0038]

[0039] 30g of compound 3 (73mmol) was suspended in 500mL of dichloromethane, followed by adding 4-aminobenzyl alcohol (11g, 90mmol), EEDQ (27g, 113mmol), and finally methanol until the solution was clear, stirred at room temperature overnight, filtered, solid dichloromethane After washing, the filtrate was concentrated to dryness to obtain the crude compound 4, and then washed with methyl tert-butyl ether to obtain 20 g of the pure product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pectin-doxorubicin conjugate, and discloses a preparation method and application of the conjugate. The pectin-doxorubicin conjugate of the present invention has a brand-new chemical structure, and can accumulate in malignant tumor tissues at a targeted high concentration for a long time, so as to achieve the purpose of increasing efficiency and reducing toxicity. The indication is chemotherapy for various solid malignant tumors .

Description

technical field [0001] The invention relates to the field of pharmacy, in particular to a pectin-doxorubicin conjugate and its preparation method and application. Background technique [0002] "Pectin-doxorubicin conjugate" targeted drug delivery system (PAC) is based on a large number of previous work and literature research, select pectin as the carrier of polymer anticancer prodrug, and through the The structure of pectin-doxorubicin can be modified so that it can be covalently combined with polypeptide-doxorubicin to form a water-soluble pectin-doxorubicin conjugate with high drug loading. [0003] PAC is a polymer conjugate with a particle size of about 200nm. Some drugs that enter the circulatory system after injection can accumulate in tumor tissue by taking advantage of the enhanced permeability and retention effect (EPR) of tumor tissue on macromolecular substances, achieving a passive targeted purpose. PAC is gradually phagocytized by tumor cells in tumor tissue,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K47/65A61K47/61A61K47/60A61K31/704A61P35/00
CPCA61K47/61A61K47/60A61K47/65A61K31/704A61P35/00C08B37/0045
Inventor 唐小海曾诚黄源芳
Owner SICHUAN YINGRUI PHARMA TECH CO